According to the Market Statsville Group (MSG), the global computer-aided drug discovery market size was valued at USD 3,146.8 million in 2021 and is projected to reach USD 10,897.9 million by 2030, growing at a CAGR of 14.8% from 2022 to 2030. The demand for computer-aided drug discovery increased due to the high efficiency reached using computer-aided drug discovery growing prevalence of chronic disease across the globe coupled with increasing investment in drug discovery projects will drive the market's growth over the forecast period. High costs and cyberattacks may hamper the market's growth. However, advancing technologies creates lucrative opportunities for the market’s growth.

COVID-19 Impact on the Global Computer-Aided Drug Discovery Market

COVID-19 had a positive impact on the market’s growth. Computer-aided molecular modeling and virtual screening played a vital role in understanding the structural aspects of multiple molecular targets of COVID-19 and identifying novel lead molecules. In addition, pharmaceutical & biotechnology and research institutes firms are adding their efforts to fight against the global pandemic. Thus, delivering a positive growth sphere to the market amid the pandemic.

Scope of the Global Computer-Aided Drug Discovery Market

On the basis of the study, the computer-aided drug discovery market is categorized into the following segments: type, therapeutic area, and end-user, at the regional and global levels.

By Type Outlook (Sales, USD Million, 2017-2030)

• Structure-based drug design
• Ligand-based drug design
• Sequence-based approaches

By Therapeutic Area Outlook (Sales, USD Million, 2017-2030)

• Neurology
• Oncology
• Cardiovascular disease
• Respiratory disease
• Diabetes
• Others

By End-User Outlook (Sales, USD Million, 2017-2030)

• Biotechnology companies
• Pharmaceutical companies
• Research laboratories

By Region Outlook (Sales, USD Million, 2017-2030)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Italy
  • France
  • UK
  • Spain
  • Poland
  • Russia
  • The Netherlands
  • Norway
  • Czech Republic
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Malaysia
  • Thailand
  • Singapore
  • Australia & New Zealand
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Northern Africa
  • Rest of MEA

Cardiovascular disease segment holds a major market share by therapeutic area

On a segmental basis, cardiovascular accounts for a major market share in 2021, due to the growing prevalence of cardiovascular diseases (CVD); CVD is a leading cause of death across the globe. For instance, as per the World Health Organization (WHO) data, cardiovascular diseases are the leading cause of death in the global scenario. In 2017, around 17.9 million deaths occurred due to cardiovascular diseases, which is 31% of all the deaths that occurred in the same year. The number is estimated to enhance and reach 22.2 million by the end of 2030. Similarly, as per the Centers for Disease Control and Prevention (CDC) data, annually, approximately 805,000 people in the US have a heart attack. Among them, 605,000 are the first heart attack victims, and 200,000 happen to people who have already had a heart attack. These factors are anticipated to drive the demand for novel drug molecules, which may surge the demand for the computer-aided drug discovery market over the forecast period.

Regional Analysis of Computer-Aided Drug Discovery Market

On a regional basis, North America accounts for the major market share in 2021. The growth is attributed to the rising cancer cases, and in order to manage that, government and pharmaceutical companies are investing in drug discovery. The growing prevalence of cancer will drive the market's growth; for instance, according to the data from the International Agency for Research on Cancer (IARC), in 2018 about 17 million new cancer cases and 9.5 million cancer deaths were recorded globally. Around 27.5 million new cancer cases and 16.3 million cancer deaths have been expected to grow in 2024. Growing cancer cases requires effective medicine and treatment. The growing cancer cases at an alarming state will demand the effective medicine for which computer-aided drug discovery plays a crucial role, propelling the market's growth across the region.

Key Market Players in the Global Computer-Aided Drug Discovery Market

Computer-aided drug discovery market has highly competitive rivalry due to the presence of various well-established market players coupled with the growing investment in drug discovery by various market players and governments. Such factors drive the market's growth, which major market players seek as an advantage and gain profit margins. Some of the major players are as follows:

• BOCSCI Inc.
• Bioduro-Sundia
• Schrödinger, Inc.
• Aragen Life Sciences Pvt. Ltd.
• Aris Pharmaceuticals, Inc
• Charles River Laboratories
• Bayer AG
• AstraZeneca,
• Albany Molecular Research Inc. (AMRI)
• Others prominent players

Recent Development

• In February 2021, Optibrium raised significant investment from Kester Capital, a UK mid-market private equity firm typically investing between £10 to £20 million (USD 12.6 to USD 15.1 million) per deal. This investment will accelerate the development of the business through organic growth and acquisition. More than 150 organizations worldwide deploy Optibrium’s technology in their research programs, including five of the top ten global pharmaceutical companies.
• In May 2020, Stony Brook University researchers adopted computing therapeutic areas to discover chemicals that activate or inhibit the viral molecules. It is expected that this research may speed up the drug discovery for the coronavirus treatment.
• In September 2019, AstraZeneca partnered with Schrodinger. On the basis of partnership, AstraZeneca is estimated to accelerate drug discovery with the assistance of Schrodinger’s advanced computing platform.

Key Issues Addressed

• What is the market size by various segmentation of the computer-aided drug discovery market by region and its respective countries?
• What is the customer buying behavior, key takeaways, and Porter's 5 forces of the computer-aided drug discovery market?
• What are the key opportunities and trends for manufacturers involved in the computer-aided drug discovery market supply chain?
• What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
• What and how regulations, schemes, patents, and policies are impacting the growth of the market?
• What are the upcoming technological solutions influencing market trends? How will existing companies adapt to the new change in technology?
• The market player positioning, top winning strategies by years, company product developments, and launches will be?
• How has COVID-19 impacted the demand and sales of computer-aided drug discovery market in the global market? Also, the expected BPS drop or rise count of the market and market predicted recovery period.
• Detailed analysis of the competitors and their latest launch, and what are the prominent startups introduced in the target market? Also, detailed company profiling of leading and prominent companies in the market.